We are live on ! Find out more
SMTI icon

Sanara MedTech
SMTI

35 hedge funds and large institutions have $19.1M invested in Sanara MedTech in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 4

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

13% more funds holding

Funds holding: 31 → 35 (+4)

10% more capital invested

Capital invested by funds: $17.4M → $19.1M (+$1.71M)

0.92% more ownership

Funds ownership: 4.6% → 5.52% (+0.92%)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
16
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.28M
2
Jane Street
Jane Street
New York
+$742K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$469K
4
HF
HRT Financial
New York
+$463K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$425K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$708K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$268K
3
6CM
683 Capital Management
New York
-$226K
4
DC
Diametric Capital
Massachusetts
-$211K
5
PCM
Prelude Capital Management
New York
-$98K

SMTI Hedge Fund Activity: Q1 2023 in Review

35 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q1 2023, worth a combined $19.1M — up 9.9% from $17.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SMTI positions and 2 closed out — a net gain of 5 holders — while 16 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.28M. The largest seller was EAM Investors, cutting an estimated $708K.

  • 35 institutional investors held Sanara MedTech (SMTI) as of Q1 2023, up from 31 in Q4 2022.
  • Funds reported $19.1M of Sanara MedTech stock for Q1 2023, up 9.9% quarter-over-quarter.
  • 7 funds opened new Sanara MedTech positions in Q1 2023 and 2 closed out, a net change of +5 holders.
  • The largest Sanara MedTech buyer in Q1 2023 was Millennium Management, an estimated $1.28M added.
  • The largest Sanara MedTech seller in Q1 2023 was EAM Investors, an estimated $708K sold.

Based on aggregated 13F filings for Q1 2023.